<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01000584</url>
  </required_header>
  <id_info>
    <org_study_id>H09-02811</org_study_id>
    <nct_id>NCT01000584</nct_id>
  </id_info>
  <brief_title>Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine</brief_title>
  <official_title>PCIRN Evaluation of Pandemic H1N12009 Influenza Vaccine in Adults, Including Randomized Comparison of Concurrent or Delayed Seasonal Influenza Vaccination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>David Scheifele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety and effectiveness (immune response) to a
      licensed H1N12009 influenza vaccine in adults when given at the same time or prior to the
      seasonal influenza vaccine. The study will enroll 300 adults (ages 20-59 years). Participants
      will be randomized into 2 groups. One group will receive one dose of a licensed H1N1 vaccine
      and one dose of the seasonal influenza vaccine at the same time; the second group will
      receive the seasonal influenza vaccine 3 weeks after receiving the licensed H1N12009
      influenza vaccine. Study procedures include: medical history, blood samples and completing a
      memory aid. Participants will be involved in study related procedures for approximately 3-6
      weeks depending upon the group assignment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of this study are two-fold:

        1. To evaluate the safety and immunogenicity of H1N12009 influenza vaccine in a convenience
           sample of adults, soon after the pandemic vaccine becomes available so as to inform the
           subsequent use of vaccine in public programs.

        2. To evaluate the compatibility of co-administered H1N12009 pandemic vaccine and seasonal
           TIV vaccine in the same group of subjects, as the option of co-administration would be
           useful for public programs.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of adverse events (AEs) for days 0-6 after each vaccination</measure>
    <time_frame>Day 7 and Day 21 post vaccination</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of serious adverse events (SAEs) and other significant health events up to 21 days after each vaccination</measure>
    <time_frame>Day 7 and Day 21 post vaccination</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Immunogenicity: Comparison of baseline and post-immunization antibody titres</measure>
    <time_frame>Day 21 post vaccination</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">309</enrollment>
  <condition>Influenza</condition>
  <condition>H1N1 2009 Influenza</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Group A: One dose of the licensed H1N1 vaccine and one dose of the seasonal influenza vaccine given concurrently</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Group B: One dose of seasonal influenza vaccine given 3 weeks after administration of one dose of the licensed H1N1 vaccine</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Arepanrix, Vaxigrip 2009/2010</intervention_name>
    <description>Group A: Single dose of Arepanrix and single dose of Vaxigrip 2009/2010 given concurrently</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Arepanrix, Vaxigrip 2009/2010</intervention_name>
    <description>Group B: Single dose of Vaxigrip 2009/2010 given 3 weeks after single dose of Arepanrix</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Adults 20-59 years of age

        Exclusion Criteria:

          -  Allergies to eggs, thimerosal, gentamicin sulphate, neomycin

          -  Life-threatening reaction to previous Flu vaccine

          -  Bleeding disorder

          -  Pregnancy

          -  Receipt of blood or blood products in past 3 months

          -  Chronic illness

          -  Compromised immune system

          -  Previous lab-confirmed H1N12009 infection

          -  Receipt of H1N12009 vaccine

          -  Receipt of Seasonal Influenza vaccine since March 2009
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Scheifele, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Allison McGeer, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Toronto, Mt Sinai Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Loeb, MD</last_name>
    <role>Study Director</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ian Gemmill, MD</last_name>
    <role>Study Director</role>
    <affiliation>Kingston, Frontenac, Lanark Health Unit</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Dionne, MD</last_name>
    <role>Study Director</role>
    <affiliation>Institut national de sante publique du Quebec</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>McMaster University</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kingston, Frontenac, Lanark Health Unit</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Toronto, Mt Sinai Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut national de sante publique du Quebec</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2009</study_first_submitted>
  <study_first_submitted_qc>October 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2009</study_first_posted>
  <last_update_submitted>April 8, 2015</last_update_submitted>
  <last_update_submitted_qc>April 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>David Scheifele</investigator_full_name>
    <investigator_title>Director Vaccine Evaluation Center</investigator_title>
  </responsible_party>
  <keyword>vaccine</keyword>
  <keyword>H1N1</keyword>
  <keyword>influenza</keyword>
  <keyword>H1N1 influenza vaccine</keyword>
  <keyword>influenza vaccine</keyword>
  <keyword>seasonal Influenza</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

